Insurers Compete in Multi Billion Pound Sale for Aegon UK Arm

More than half a dozen of the United Kingdom’s largest insurers have been identified as potential bidders for Aegon’s UK arm, in a transaction expected to raise between £1.5 billion and £3 billion. A source at a prominent City investment bank indicated that the deal could involve the sale of the business as a single entity or be split into multiple parts. Firms such as Chesnara, Phoenix Group, Aviva, Royal London, M&G, Lloyds Banking Group and, with less likelihood, Legal & General have emerged as possible suitors.

Ross McNally, an equity sales trader at Panmure Liberum, explained two primary scenarios for the sale: either the entirety of Aegon UK will be acquired by a large insurer, with Phoenix or Lloyds being strong candidates, or sections of the business could be sold off separately to different buyers. The transaction would involve assets from its workplace pension division and two adviser platforms, The Aegon Platform and Aegon Retirement Choices. Notably, the company’s asset management unit will remain separate and unaffected by these potential changes.

The insurer, which employs approximately 2,500 staff across the UK, recently announced plans to move its head office to the United States and rebrand under its largest subsidiary, Transamerica. This is part of a broader restructuring initiative, including a review of its Edinburgh-based business and the prospect of divestment. Aegon’s management outlined that the review is set for completion in the first half of 2026, with the overarching relocation to the US aimed for early 2028.

Market analysts believe that divestment is the most probable outcome of this review. Michael Huttner, an equity insurance analyst at Berenberg, commented that securing a buyer for the entire operation may prove difficult, as many interested parties might only seek specific sections. Berenberg noted the continued interest from UK life insurers, particularly those experiencing ongoing structural net outflows, as a factor making Aegon UK an appealing opportunity in the sector.

Aegon’s shares are anticipated to shift their primary trading volumes from Euronext Amsterdam to the New York Stock Exchange, reflecting the increasing dominance of US operations, which now comprise 70 percent of the company’s global business. Chief Executive Lard Friese affirmed that relocating the headquarters acknowledges the current structure of Aegon’s business and is designed to strengthen the company’s focus on building a prominent franchise in the United States.

Both Aegon and Lloyds Banking Group have refrained from commenting on ongoing speculation. Phoenix Group has similarly declined to address rumours concerning a potential deal. The future of Aegon UK will be clarified when the Strategic Review reaches its conclusion in the coming months.